The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.73 billion in 2024 to $6.14 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products.
The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $8.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, personalized treatment options. Major trends in the forecast period include innovative topical formulations, advancements in laser technologies, focus on combination therapies, personalized treatment approaches, rising demand for natural products.
The expected increase in the prevalence of pigmentation disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass various conditions affecting the coloration of the skin, hair, and eye iris, typically resulting from issues with melanin, the pigment produced by melanocytes. Treatment options for hyperpigmentation disorders vary based on the underlying cause and severity, with mild cases often managed through over-the-counter topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening properties. For example, a report from the Centers for Disease Control (CDC) in March 2023 highlighted an increase in Candida auris cases in the US from 476 in 2019 to 1,471 in 2021. Additionally, the National Psoriasis Foundation reported in December 2022 that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders' prevalence is expected to drive the growth of the hyperpigmentation disorders treatment market.
The growth of the hyperpigmentation disorder treatment market is further propelled by increasing cosmetic concerns. Cosmetic concerns refer to worries or considerations related to one's physical appearance, beauty, or aesthetics. The rising focus on cosmetic concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. Reports from the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023 revealed that plastic surgeons are expected to perform over 14.9 million surgical and 18.8 million non-surgical operations in 2022, reflecting an overall increase of 11.2%. The heightened emphasis on cosmetic concerns is a significant driver behind the growth of the hyperpigmentation disorder treatment market.
Major companies in the hyperpigmentation disorders treatment market are concentrating on developing glycolic acid solutions to enhance their market position and secure a competitive edge. Glycolic acid solutions are skincare formulations that contain glycolic acid, an alpha hydroxy acid (AHA) recognized for its exfoliating benefits, which help to improve skin texture, brightness, and overall appearance by encouraging cell turnover. For example, in February 2024, L'Oréal SA, a personal care company based in France, introduced the Glycolic Bright Dark Circle Eye Serum, designed to address dark circles and dullness around the eyes. This innovative serum utilizes glycolic acid for its exfoliating effects, promoting brighter skin and improved texture. The formulation likely also incorporates hydrating ingredients to nourish the sensitive eye area.
Major players in the hyperpigmentation disorder treatment market are strategically launching innovative products to meet the growing demand for effective and safe hyperpigmentation treatment. A noteworthy example is the Cyspera Intensive System, unveiled by Cyspera (Scientis SA), a Switzerland-based dermatology company. This revolutionary three-step hyperpigmentation treatment is meticulously designed to target persistent brown patches and dark spots. The system features a proprietary Cysteamine Isobionic-Amide Complex, a patented melanosomal transfer inhibitor within the vitamin B3 family. This complex collaborates synergistically with cysteamine to deliver three powerful effects. In essence, the Cyspera Intensive System emerges as a promising new option for hyperpigmentation treatment, ensuring safety and efficacy for all skin types without harsh chemicals.
In July 2023, Reveal Lasers LLC, a US-based manufacturer of aesthetic lasers and RF devices, merged with NEOconcepts LLC. This merger allows Reveal Lasers to acquire the AgeJET Advanced Plasma Skin Therapy Device, facilitating its entry into a new treatment area and strengthening AgeJET's presence in the US market. NEOconcepts LLC specializes in providing aesthetic treatment products and devices.
Major companies operating in the hyperpigmentation disorder treatment market include Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.
North America was the largest region in the hyperpigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Hyperpigmentation disorder treatment involves various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.
Treatment types in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other treatments. Cosmeceuticals are cosmetics with active ingredients that may have therapeutic effects on the skin. They are utilized to treat various conditions, including melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications. These treatments are administered by various end-users, including hospitals, esthetic clinics, dermatology centers, and other healthcare facilities.
The hyperpigmentation disorder treatment market research report is one of a series of new reports that provides hyperpigmentation disorder treatment optical components market statistics, including hyperpigmentation disorder treatment optical components industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment optical components market share, detailed hyperpigmentation disorder treatment optical components market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment optical components industry. This hyperpigmentation disorder treatment optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $8.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, personalized treatment options. Major trends in the forecast period include innovative topical formulations, advancements in laser technologies, focus on combination therapies, personalized treatment approaches, rising demand for natural products.
The expected increase in the prevalence of pigmentation disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass various conditions affecting the coloration of the skin, hair, and eye iris, typically resulting from issues with melanin, the pigment produced by melanocytes. Treatment options for hyperpigmentation disorders vary based on the underlying cause and severity, with mild cases often managed through over-the-counter topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening properties. For example, a report from the Centers for Disease Control (CDC) in March 2023 highlighted an increase in Candida auris cases in the US from 476 in 2019 to 1,471 in 2021. Additionally, the National Psoriasis Foundation reported in December 2022 that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders' prevalence is expected to drive the growth of the hyperpigmentation disorders treatment market.
The growth of the hyperpigmentation disorder treatment market is further propelled by increasing cosmetic concerns. Cosmetic concerns refer to worries or considerations related to one's physical appearance, beauty, or aesthetics. The rising focus on cosmetic concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. Reports from the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023 revealed that plastic surgeons are expected to perform over 14.9 million surgical and 18.8 million non-surgical operations in 2022, reflecting an overall increase of 11.2%. The heightened emphasis on cosmetic concerns is a significant driver behind the growth of the hyperpigmentation disorder treatment market.
Major companies in the hyperpigmentation disorders treatment market are concentrating on developing glycolic acid solutions to enhance their market position and secure a competitive edge. Glycolic acid solutions are skincare formulations that contain glycolic acid, an alpha hydroxy acid (AHA) recognized for its exfoliating benefits, which help to improve skin texture, brightness, and overall appearance by encouraging cell turnover. For example, in February 2024, L'Oréal SA, a personal care company based in France, introduced the Glycolic Bright Dark Circle Eye Serum, designed to address dark circles and dullness around the eyes. This innovative serum utilizes glycolic acid for its exfoliating effects, promoting brighter skin and improved texture. The formulation likely also incorporates hydrating ingredients to nourish the sensitive eye area.
Major players in the hyperpigmentation disorder treatment market are strategically launching innovative products to meet the growing demand for effective and safe hyperpigmentation treatment. A noteworthy example is the Cyspera Intensive System, unveiled by Cyspera (Scientis SA), a Switzerland-based dermatology company. This revolutionary three-step hyperpigmentation treatment is meticulously designed to target persistent brown patches and dark spots. The system features a proprietary Cysteamine Isobionic-Amide Complex, a patented melanosomal transfer inhibitor within the vitamin B3 family. This complex collaborates synergistically with cysteamine to deliver three powerful effects. In essence, the Cyspera Intensive System emerges as a promising new option for hyperpigmentation treatment, ensuring safety and efficacy for all skin types without harsh chemicals.
In July 2023, Reveal Lasers LLC, a US-based manufacturer of aesthetic lasers and RF devices, merged with NEOconcepts LLC. This merger allows Reveal Lasers to acquire the AgeJET Advanced Plasma Skin Therapy Device, facilitating its entry into a new treatment area and strengthening AgeJET's presence in the US market. NEOconcepts LLC specializes in providing aesthetic treatment products and devices.
Major companies operating in the hyperpigmentation disorder treatment market include Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.
North America was the largest region in the hyperpigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Hyperpigmentation disorder treatment involves various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.
Treatment types in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other treatments. Cosmeceuticals are cosmetics with active ingredients that may have therapeutic effects on the skin. They are utilized to treat various conditions, including melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications. These treatments are administered by various end-users, including hospitals, esthetic clinics, dermatology centers, and other healthcare facilities.
The hyperpigmentation disorder treatment market research report is one of a series of new reports that provides hyperpigmentation disorder treatment optical components market statistics, including hyperpigmentation disorder treatment optical components industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment optical components market share, detailed hyperpigmentation disorder treatment optical components market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment optical components industry. This hyperpigmentation disorder treatment optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Hyperpigmentation Disorder Treatment Market Characteristics3. Hyperpigmentation Disorder Treatment Market Trends and Strategies4. Hyperpigmentation Disorder Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Hyperpigmentation Disorder Treatment Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Hyperpigmentation Disorder Treatment Market34. Recent Developments in the Hyperpigmentation Disorder Treatment Market
5. Global Hyperpigmentation Disorder Treatment Growth Analysis and Strategic Analysis Framework
6. Hyperpigmentation Disorder Treatment Market Segmentation
7. Hyperpigmentation Disorder Treatment Market Regional and Country Analysis
8. Asia-Pacific Hyperpigmentation Disorder Treatment Market
9. China Hyperpigmentation Disorder Treatment Market
10. India Hyperpigmentation Disorder Treatment Market
11. Japan Hyperpigmentation Disorder Treatment Market
12. Australia Hyperpigmentation Disorder Treatment Market
13. Indonesia Hyperpigmentation Disorder Treatment Market
14. South Korea Hyperpigmentation Disorder Treatment Market
15. Western Europe Hyperpigmentation Disorder Treatment Market
16. UK Hyperpigmentation Disorder Treatment Market
17. Germany Hyperpigmentation Disorder Treatment Market
18. France Hyperpigmentation Disorder Treatment Market
19. Italy Hyperpigmentation Disorder Treatment Market
20. Spain Hyperpigmentation Disorder Treatment Market
21. Eastern Europe Hyperpigmentation Disorder Treatment Market
22. Russia Hyperpigmentation Disorder Treatment Market
23. North America Hyperpigmentation Disorder Treatment Market
24. USA Hyperpigmentation Disorder Treatment Market
25. Canada Hyperpigmentation Disorder Treatment Market
26. South America Hyperpigmentation Disorder Treatment Market
27. Brazil Hyperpigmentation Disorder Treatment Market
28. Middle East Hyperpigmentation Disorder Treatment Market
29. Africa Hyperpigmentation Disorder Treatment Market
30. Hyperpigmentation Disorder Treatment Market Competitive Landscape and Company Profiles
31. Hyperpigmentation Disorder Treatment Market Other Major and Innovative Companies
35. Hyperpigmentation Disorder Treatment Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Hyperpigmentation Disorder Treatment Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on hyperpigmentation disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hyperpigmentation disorder treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hyperpigmentation disorder treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Treatment Type: Cosmeceuticals; Laser Therapy; Chemical Peels; Microdermabrasion; Phototherapy; Other Treatments2) By Disease Indication: Melasma; Post-Inflammatory Hyperpigmentation; Solar Lentigines; Other Disease Indications
3) By End-Users: Hospitals; Esthetic Clinics and Dermatology Centers; Other End-Users
Subsegments:
1) By Cosmeceuticals: Topical Creams and Gels; Serums and Lotions; Sunscreens; Laser Therapy2) By Laser Therapy: Fractional Laser Resurfacing; Intense Pulsed Light (IPL) Therapy
3) By Chemical Peels: Superficial Peels; Medium Depth Peels; Deep Peels
4) By Microdermabrasion: Crystal Microdermabrasion; Diamond Microdermabrasion
5) By Phototherapy: Blue Light Therapy; Red Light Therapy
6) By Other Treatments: Cryotherapy; Dermal Fillers; Microneedling
Key Companies Mentioned: Vivier Pharma; Obagi Cosmeceuticals LLC; RXi Pharmaceuticals Corporation; EpiPharm AG; Laboratories Pierre Fabre
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Vivier Pharma
- Obagi Cosmeceuticals LLC
- RXi Pharmaceuticals Corporation
- EpiPharm AG
- Laboratories Pierre Fabre
- SkinCeuticals
- Galderma S.A.
- Allergan PLC.
- Bayer AG
- Lumenis Be Ltd.
- Aerolase Corporation
- Candela Corporation
- Cynosure
- PCA Skin
- Episciences Inc.
- La Roche-Posay
- L'Oréal S.A.
- Pierre Fabre Laboratories
- Alvogen Inc.
- Clinuvel Pharmaceuticals Ltd.
- Clarify Medical Inc.
- Incyte Corporation
- Dr. Reddy’s Laboratories Ltd.
- Glenmark Pharmaceuticals Ltd.
- Teva Pharmaceutical Industries
- SkinMedica Inc.
- Neutrogena Corporation
- Paula's Choice Inc.
- ZO Skin Health Inc.
- Estée Lauder Companies Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 6.14 Billion |
| Forecasted Market Value ( USD | $ 8.6 Billion |
| Compound Annual Growth Rate | 8.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
